首页|松果菊苷下调Skp2的表达抑制胶质母细胞瘤上皮间质转化及胶质瘤干细胞干性

松果菊苷下调Skp2的表达抑制胶质母细胞瘤上皮间质转化及胶质瘤干细胞干性

扫码查看
目的 研究松果菊苷(ECH)对胶质母细胞瘤(GBM)的上皮间质转化(EMT)及其对GBM干细胞的影响,并探讨其分子机制.方法 ①体外实验:将GBMU87和U251细胞以0、5、10和20 μmol·L-1 ECH浓度处理24 h.采用CCK-8法评估细胞活性;进行克隆形成实验以测定克隆能力;通过Transwell实验评估迁移和侵袭能力;利用球形成实验评价GBM干细胞的成球能力;通过细胞免疫荧光检测干细胞标志物;使用Western blot分析EMT和干细胞相关蛋白表达.②体内实验:在裸鼠皮下注射U87细胞,每组5只.实验组腹腔注射ECH,对照组注射等体积溶剂.最后测定肿瘤体积、重量和体重,并用Western blot分析肿瘤中的Skp2、EMT和干细胞相关蛋白表达.结果 ①体外实验显示,相较于0 μmol·L-1 ECH组,10、20 μmol·L-1 ECH 处理显著降低了细胞活性(P<0.05);在 5、10 和 20 µmol·L-1 ECH组中克隆形成数量显著减少(P<0.05);迁移和侵袭能力在5、10 μmol·L-1 ECH组中随浓度升高而降低(P<0.05);成球能力和干细胞标志物表达及Skp2、EMT和干细胞特性相关蛋白表达在5、10 μmol·L-1 ECH组中均显著降低(P<0.05).②体内实验显示,ECH处理小鼠的肿瘤体积和重量显著小于对照组(P<0.05),且Skp2、EMT(Vimentin、Snail)和干细胞标志物(Sox2、Nestin)的表达显著减少(P<0.05);两组小鼠体重差异无统计学意义(P>0.05).结论 ECH通过降低Skp2表达抑制GBM的EMT和干细胞特性.
Echinacoside inhibits Skp2-induced epithelial-mesenchymal transition and stemness in glioblastoma
Objective To determine the impact of echinacoside(ECH)on the epithelial-mesenchymal transition(EMT)and glioma stem cell characteristics in glioblastoma,and to elucidate related molecular mechanism.Methods ① In vitro experiments:glioblastoma U87 and U251 cells were cultured and treated with 0,5,10,and 20 μmol·L-1 ECH for 24 hours;the cell viability was evaluated with the CCK-8 assay;clonogenic capacity was determined by the colony formation assay,migration and invasion by transwell assay,and stem cell potential by sphere formation assay.The expression of stem cell markers was assessed with immunofluorescence;EMT and stemness-related protein expressions were analyzed with Western blot.② In vivo experiments:U87 cells were subcutaneously implanted into nude mice(five mice in each group).The experimental group was administered daily intraperitoneal injections of ECH,while the control group received a corresponding volume of the vehicle.At the end of the experiment,tumor volume,mouse weight,tumor weight were measured,and Skp2,EMT,and stemness-related protein expressions in tumors were analyzed by Western blot.Results ① In vitro experiments showed that,compared to the 0 μmol·L-1 ECH group,the 10 and 20 μmol·L-1 ECH groups significantly reduced cell viability(P<0.05);the number of colonies formed was significantly decreased in the 5,10,and 20 μmol·L-1 ECH groups(P<0.05);migration and invasion abilities were reduced in the 5 and 10 μmol·L-1 ECH groups(P<0.05);spheroid formation ability and stem cell marker expression,Skp2 and EMT expression,and stem cell characteristic proteins significantly decreased in the 5 and 10 μmol·L-1 ECH groups(P<0.05).(2)In vivo experiments showed that,tumor volume and weight in mice treated with ECH were obviously smaller than those in the control group(P<0.05),and the expression of Skp2 and EMT markers(Vimentin,Snail),and stem cell markers(Sox2,Nestin)significantly decreased;there was no significant difference in the body weight between both groups.Conclusion ECH inhibits the EMT and diminishes stemness in glioblastoma by downregulating Skp2 expression.

glioblastomaechinacosideepithelial-mesenchymal transitionstemnessSkp2

吴振德、王兆涛、鞠其超、张波

展开 >

厦门长庚医院神经外科,福建 厦门 361028

广州医科大学附属第二医院神经外科,广州 560210

胶质母细胞瘤 松果菊苷 上皮间质转化 干细胞干性 Skp2

广东省自然科学基金面上项目

2019A1515010926

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(3)
  • 29